Par Health Issues Voluntary Nationwide Recall Of Two Lots Of Dexmedetomidine Hcl In 0.9% Sodium Chloride Injection Due To The Presence Of Particulate Matter
- Recalling firm
- Par Health
- Product
- Two Lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection
- Reason
- ROCHESTER, MI– September 18, 2026 –Par Health is voluntarily recalling two lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection 400 mcg/100 mL (4 mcg/mL) to the hospital level. The product is being recalled due to the presence of particulate matter identified as cellulose or stopper materia
- Category
- drug recall
- Country
- United States
- Agency
- FDA-MEDWATCH-RSS
- Recall date
- 2026-09-21
- Status
- Ongoing
Official recall notice from FDA-MEDWATCH-RSS
Recall details on Nibble Recalls: https://trynibble.app/recalls/e88b59cb-495d-40b0-857d-ba48291699ec